Evidence map›Paper›PMID 27363505›Full record

ArticleJournal of orthopaedic surgery and research2016

Assessing the negative impact of phenyl alkanoic acid derivative, a frequently prescribed drug for the suppression of pain and inflammation, on the differentiation and proliferation of chondrocytes.

Seyit Ali Gumustas, İbrahim Yilmaz, Mehmet Isyar, Duygu Yasar Sirin, Ahmet Guray Batmaz, Ali Akin Ugras, Kadir Oznam, Zafer Ciftci, Mahir Mahirogullari

Open access · goldAbstract read
In one paragraph

Article in Journal of orthopaedic surgery and research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Seyit Ali GumustasDepartment of General Secretariat of the Public Hospitals Union, Republic of Turkey, Ministry of Health, 59100, Tekirdag, Turkey.
İbrahim YilmazDepartment of Pharmacovigilance, Materiovigilance and Rational Use of Drugs, Republic of Turkey, Ministry of Health, 59100, Tekirdag, Turkey. ibrahimyilmaz77@yahoo.com.ORCID http://orcid.org/0000-0003-2003-6337
Mehmet IsyarClinics of Orthopaedic and Traumatology, Central Hospital Health Group, 34742, Istanbul, Turkey.
Duygu Yasar SirinDepartment of Molecular Biology and Genetic, Namik Kemal University Faculty of Arts and Sciences, 59100, Tekirdag, Turkey.
Ahmet Guray BatmazDepartment of Orthopaedic and Traumatology, Istanbul Medipol University School of Medicine, 34214, Istanbul, Turkey.
Ali Akin UgrasDepartment of Orthopaedic and Traumatology, Istanbul Medipol University School of Medicine, 34214, Istanbul, Turkey.
Kadir OznamDepartment of Orthopaedic and Traumatology, Istanbul Medipol University School of Medicine, 34214, Istanbul, Turkey.
Zafer CiftciDepartment of Otolaryngology and Head and Neck Surgery, Namik Kemal University School of Medicine, 59100, Tekirdag, Turkey.
Mahir MahirogullariDepartment of Orthopaedic and Traumatology, Memorial Hospital, 34384, Istanbul, Turkey.
Istanbul Medipol University · TRMinistry of Health · TRTekirdağ Namık Kemal University · TRIstanbul Memorial Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-steroidal anti-inflammatory drugs (NSAIDs) are frequently prescribed to relieve pain and inflammation. These NSAIDs have also analgesic effects and can be administered via oral, injectable, and topical routes. During inflammation, a number of synovial mediators and cytokines are released which decrease the pH level of the synovial fluid. Administration of acidic NSAIDs further decreases the pH levels and hence contributes to the destruction of the cartilage. To our knowledge, no cellular-based study regarding the chondrotoxicity of phenyl alkanoic acid derivatives on NSAIDs was conducted before. Thus, the aim of this pioneering study was to examine the effect of frequently prescribed NSAIDs, a phenyl alkanoic acid derivative, flurbiprofen, on the proliferation and differentiation of human primer chondrocyte cultures in vitro.

methodsPrimer chondrocyte cultures were prepared from osteochondral tissue obtained during surgery for gonarthrosis. Samples not exposed to the pharmacological agent were used as the control group. The samples were treated with 1, 10, 100, 250, 500, or 1000 μM of the agent for 24, 48, and 72 h. The cell viability, toxicity, and proliferation were assessed with MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) analysis and prechondrocytic precursor stage-specific embryonic antigen-1 (SSEA-1) expression using a commercial ELISA kit spectrophotometrically. The surface morphology of the samples in each group was compared using an inverted light microscope and an environmental scanning electron microscope (ESEM). An analysis of variance was used to compare between-group differences. Tukey's honest significant difference (HSD) method (95 % confidence interval) was used to evaluate the differences and significance in averages. The alpha significance value was considered <0.01.

resultsStatistically significant cytotoxicity was observed in the treatment groups. NSAID had a significant negative effect on the proliferation and differentiation of chondrocytes as compared to the control group (p < 0.01).

conclusionBefore administering phenyl alkanoic acid derivatives in the clinical setting, their role in suppressing the proliferation and differentiation of chondrocytes should be taken into account. Thus, caution should be given when prescribing these drugs.

Indexed as

AnalgesicsAnti-Inflammatory Agents, Non-SteroidalCell DifferentiationCell ProliferationCells, CulturedChondrocytesHumansInflammationPainSingle-Blind MethodAnalgesicsAnti-Inflammatory Agents, Non-SteroidalAntigen-1ChondrotoxicityEmbryonicPhenyl alkanoic acidProliferationStage-specific

Identifiers

PMID27363505
PMCPMC4929725
OpenAlexW2464581519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.